Related Experiment Video
Updated: Jul 10, 2025

Osteoclast Derivation from Mouse Bone Marrow
Published on: November 6, 2014
New flavan trimer from Daemonorops draco as osteoclastogenesis inhibitor
Ayaka Tsuchiya1, Maki Suzuki2, Ryotaro Ito2
1The United Graduate School of Agricultural Science, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu 501-1193, Japan.
Dragon's blood resin yielded two new compounds. Compound 7 and 1, derived from Daemonorops draco, demonstrated anti-osteoclastogenesis activity, suggesting potential therapeutic applications.
Area of Science:
- Natural Product Chemistry
- Pharmacology
- Medicinal Chemistry
Background:
- Dragon's blood, a red resin from various plants, is recognized for its medicinal properties, particularly wound healing.
- Daemonorops draco is a source of bioactive compounds with therapeutic potential.
Purpose of the Study:
- To isolate and characterize new compounds from Daemonorops draco dragon's blood.
- To evaluate the anti-osteoclastogenesis activity of isolated compounds.
Main Methods:
- Isolation of compounds using chromatographic techniques.
- Structure elucidation utilizing Nuclear Magnetic Resonance (NMR), MALDI-TOF MS, and Electronic Circular Dichroism (ECD) analysis.
- Assessment of anti-osteoclastogenesis activity through in vitro assays.
Main Results:
- Two novel compounds (7 and 8) and eight known compounds (1-6, 9, 10) were isolated from Daemonorops draco.
- Compound 8 was identified as a quinone methide derivative of flavan, and compound 7 as a flavan trimer.
- Compounds 1 and 7 exhibited significant anti-osteoclastogenesis activity with IC50 values of 31.3 μM and 36.8 μM, respectively.
Conclusions:
- The study successfully identified new and known compounds from Daemonorops draco dragon's blood.
- Compounds 1 and 7 show promise as inhibitors of osteoclastogenesis, warranting further investigation for potential therapeutic applications in bone-related diseases.
More Related Videos
08:53Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
Published on: January 1, 2017
11:47A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Fractures: Bone Repair
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...